Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ETHYLENEDIAMINE Cause Therapy non-responder? 28 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 28 reports of Therapy non-responder have been filed in association with ETHYLENEDIAMINE. This represents 62.2% of all adverse event reports for ETHYLENEDIAMINE.

28
Reports of Therapy non-responder with ETHYLENEDIAMINE
62.2%
of all ETHYLENEDIAMINE reports
8
Deaths
28
Hospitalizations

How Dangerous Is Therapy non-responder From ETHYLENEDIAMINE?

Of the 28 reports, 8 (28.6%) resulted in death, 28 (100.0%) required hospitalization, and 8 (28.6%) were considered life-threatening.

Is Therapy non-responder Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ETHYLENEDIAMINE. However, 28 reports have been filed with the FAERS database.

What Other Side Effects Does ETHYLENEDIAMINE Cause?

Drug hypersensitivity (37) Drug ineffective (32) Drug intolerance (32) Condition aggravated (31) Hepatotoxicity (31) Musculoskeletal stiffness (31) Pain in extremity (31) Arthralgia (30) Infection (30) Joint swelling (30)

What Other Drugs Cause Therapy non-responder?

ETANERCEPT (3,472) APREMILAST (3,360) METHOTREXATE (2,965) RITUXIMAB (2,731) ADALIMUMAB (2,595) PREDNISONE (2,563) TREPROSTINIL (2,289) INFLIXIMAB (2,122) TOCILIZUMAB (1,775) HYDROXYCHLOROQUINE (1,699)

Related Pages

ETHYLENEDIAMINE Full Profile All Therapy non-responder Reports All Drugs Causing Therapy non-responder ETHYLENEDIAMINE Demographics